Novo Nordisk (Switzerland)

Recent papers from Novo Nordisk (Switzerland)

1. Single-Pass Perfusion of the Mouse Kidney In Situ for Functional and Pharmacological StudiesJournal of Visualized Experiments · 2026
2. CV inflammation prevalence and clinical biomarkers (hsCRP, IL-6 and NT-proBNP) levels in adults with ASCVD and CKD in KSA and UAE: Insights from the INFLAMEAST real-world studyEuropean Heart Journal · 2026
3. From stochastic systems to governed intelligence: a neurosymbolic path for pharmaExpert Opinion on Drug Discovery · 2026
4. Adipose tissue-on-Chip platforms for disease modelling, drug discovery and pharmacokinetic modellingAdvanced Drug Delivery Reviews · 2026
5. Burden of Systemic Inflammation Among Individuals with Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease in Northern ChinaCardiology and Therapy · 2026
6. Modelling the Clinical and Complication‐Related Economic Burden of Therapeutic Inertia in People With Type 2 Diabetes in ChinaDiabetes Obesity and Metabolism · 2026
7. Mechanism of action and impact on thrombin generation of denecimig (Mim8), emicizumab, and zemocimig (NXT007): comparative analysis using sequence-identical analogsResearch and Practice in Thrombosis and Haemostasis · 2026
8. Tetrahydrouridine pretreatment increases tissue exposure of ¹⁴ C-decitabine in miceXenobiotica · 2026
9. Cartilage intermediate layer protein (CILP) in cardiac fibrosis: Protective or pathogenic?Matrix Biology · 2026
10. Real‐World Unmet Treatment Needs for Patients With Haemophilia: Results From the Global Adelphi Disease Specific Programme DatabaseHaemophilia · 2026
11. Targeting macrophages in liver fibrosisFrontiers in Immunology · 2026
12. Biomarkers in preclinical and early Alzheimer’s disease in China: a scoping reviewThe Journal of Prevention of Alzheimer s Disease · 2026
13. How Filipinos View ObesityJournal of the ASEAN Federation of Endocrine Societies · 2026
14. An update on the European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: biomarker and anti-drug-antibody assaysBioanalysis · 2026
15. Improved Glycaemic Control with IDegLira in Chinese Adults with Type 2 Diabetes in Real-World Settings: A Retrospective, Database Cohort StudyDiabetes Therapy · 2026
16. The Future of the Obesity Management Landscape: Challenges, Opportunities and SolutionsObesity Science & Practice · 2026
17. Evidence map and gap analysis of metabolic change in pediatric growth hormone deficiency treated with growth hormonePediatric Investigation · 2026
18. Impact of Idiopathic Short Stature (ISS) on children’s well-being: A nation-wide study of short Danish childrenJournal of the Endocrine Society · 2026
19. The healthcare resource utilization and costs associated with metabolic dysfunction-associated steatohepatitis among Medicare beneficiaries: a retrospective cohort studyJournal of Medical Economics · 2026
20. Cost‐utility of once‐weekly insulin icodec versus once‐daily basal insulins for type 2 diabetes in ChinaDiabetes Obesity and Metabolism · 2026